Febrile Neutropenia in Acute Myeloblastic Leukemia (AML) clinical and microbiological features of infectious episodes and evaluation of mortality

被引:0
|
作者
Nunez, M. J. [1 ]
Sgromo, M. [1 ]
Lacal, V. [1 ]
Nunez, S. [1 ]
Sabater, L. [1 ]
Corazza, R. [1 ]
Balinotti, S. [1 ]
Veron, M. T. [1 ]
机构
[1] Sanatorio Guemes Hosp Privado, Buenos Aires, DF, Argentina
关键词
D O I
10.1016/j.ijid.2018.04.3617
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Fri_Statio
引用
收藏
页码:84 / 85
页数:2
相关论文
共 50 条
  • [41] Molecular Landscape and Clinical Features of Acute Myeloid Leukemia (AML) with Complex Karyotype (CK)
    Mrozek, Krzysztof
    Eisfeld, Ann-Kathrin
    Kohlschmidt, Jessica
    Carroll, Andrew J., III
    Nicolet, Deedra
    Blachly, James S.
    Walker, Christopher J.
    Wang, Eunice S.
    Uy, Geoffrey L.
    Kolitz, Jonathan E.
    Powell, Bayard L.
    Blum, William
    Stone, Richard M.
    Byrd, John C.
    Bloomfield, Clara D.
    BLOOD, 2017, 130
  • [42] Survivorship Struggles: Navigating Etiologies and Clinical Parameters of Febrile Neutropenia During Induction Chemotherapy in Acute Leukemia Patients
    Khan, Muhammad Haris
    Wattoo, Muhammad Adnan
    Butt, Habib ur Rehman
    Zaid, Muhammad
    Tahir, Umair
    Kaneez, Mehwish
    Joyia, Usaid Munir
    Bukhari, Syed Faheem
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [43] Evaluation of the effects of regulatory T cells on survival outcomes in patients with acute leukemia who developed febrile neutropenia
    Calik, Sebnem
    Bilgir, Oktay
    Demir, Ismail
    Tosun, Selma
    Ozdemir, Yeliz
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2025, 53 (03)
  • [44] Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004
    K Bochennek
    A Hassler
    C Perner
    J Gilfert
    S Schöning
    T Klingebiel
    D Reinhardt
    U Creutzig
    T Lehrnbecher
    Blood Cancer Journal, 2016, 6 : e382 - e382
  • [45] Identification of Predictors for Uncomplicated, Low-Risk Febrile Neutropenia (FN) Admissions for Patients with Acute Myeloid Leukemia (AML) Following Intensive Chemotherapy
    Ali, Zahra
    Othus, Megan
    Walter, Roland
    Halpern, Anna
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S193 - S194
  • [46] MINIMAL RESIDUAL DISEASE IN ACUTE MYELOBLASTIC-LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROMES (MDS) - MOLECULAR CYTOGENETICS PREDICTS CLINICAL RELAPSE
    ANDREEFF, M
    LEAHY, J
    GOODACRE, A
    DRACH, D
    SANCHEZWILLIAMS, G
    PINKEL, D
    DRACH, J
    BLOOD, 1993, 82 (10) : A36 - A36
  • [47] Prospective Evaluation of Infection Episodes in Cancer Patients in a Tertiary Care Academic Center: Microbiological Features and Risk Factors for Mortality
    Basaran, Nursel Calik
    Karaagaoglu, Ergun
    Hascelik, Gulsen
    Tanriover, Mine Durusu
    Akova, Murat
    TURKISH JOURNAL OF HEMATOLOGY, 2016, 33 (04) : 311 - 319
  • [48] Clinical Features and Diagnostic Delay of Tuberculosis (TB) in Patients with Acute Myeloid Leukemia. (AML)
    Bravo Villa, Veronica
    Martinez Moreno, Emmanuel
    Zapata, Nidia
    BLOOD, 2019, 134
  • [49] CLINICAL FEATURES AND OUTCOMES OF HYPOCELLULAR ACUTE MYELOID LEUKEMIA IN ADULTS: KOREAN AML REGISTRY DATA
    Song, I. C.
    Jo, D. Y.
    Kim, H. J.
    Min, Y. H.
    Hong, D. S.
    Lee, W. S.
    Kim, H. J.
    Lee, J. H.
    Park, J.
    Shin, H. J.
    HAEMATOLOGICA, 2015, 100 : 384 - 384
  • [50] Clinical features and outcomes of hypocellular acute myeloid leukemia in adults A Korean AML registry data
    Song, Ik-Chan
    Jo, Deog-Yeon
    Kim, Hyeoung-Joon
    Min, Yoo-Hong
    Hong, Dae Sik
    Lee, Won-Sik
    Shin, Ho-Jin
    Lee, Je-Hwan
    Park, Jinny
    Kim, Hee-Je
    MEDICINE, 2021, 100 (01) : E24185